Related Experiment Video
Updated: Feb 9, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Paediatric antidepressants: Benefits and risks
David Healy1, Joanna Le Noury2, Jon Jureidini3
1Department of Psychiatry, Hergest Unit, Bangor, Wales, UK.
Abstract:
The data supporting the use of "antidepressants" in children and adolescents is largely unavailable. Academic publications give a different picture as regards benefits and harms to publications from regulatory other sources. Despite disagreements about the data driving use of these medicines, in practice "antidepressants" may now be the most commonly used drugs by adolescent girls, and children's mental health services are attracting increasing attention.This paper reviews the difficulties surrounding the data. It outlines a case for benefits (as well as risks) that would require physicians to exert a greater degree of professional autonomy than service managers might wish.
Related Concept Videos
Benefits of Self-Esteem
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Relative Risk
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

